J06BB04 • hepatitis B immunoglobulin • Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins
Hepatitis B immunoglobulin is a medication used to prevent hepatitis B virus (HBV) infection in individuals exposed to the virus, such as newborns of infected mothers or individuals with accidental exposure. It contains antibodies that neutralize the virus, providing immediate protection.
The medication is administered via intramuscular or intravenous injection, according to the doctor's instructions. It is effective in preventing HBV infection when given promptly after exposure.
Side effects may include pain at the injection site, fever, fatigue, and, in rare cases, severe allergic reactions. Close monitoring is essential during treatment.
Consult your doctor to discuss the benefits and risks of treatment with hepatitis B immunoglobulin. Follow the administration instructions to ensure therapy effectiveness.
Substance: hepatitis B immunoglobulin
Date of last drug list: 01-01-2019
Commercial code: W41749001
Concentration: 50UI / ml
Pharmaceutical form: powder + solvent infusion solution
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: LFB - BIOMEDICAMENTS - FRANTA
Holder: LFB - BIOMEDICAMENTS - FRANTA
Number: 5129/2012/01
Shelf life: 3 years-after packing for marketing;after reconstitution-se utlilizeaza imediat